Company
AQ Biotech´s start goes back to 2017 with the aim to improve the early detection of diseases using biological sampling and the E-TRF method. After a groundbreaking innovation in late 2020 to engineer the M13 phage to have affinity towards a specific color dye, the company started extensive R&D efforts to apply it to other phages and to detect diseases, which are hard to diagnose.
Today, the company has a strong patent portfolio around the phage-biosensor method. AQ Biotech works together with world class science institutes and their clinical researchers in Finland, China and in the US, applying its biosensor method to revolutionize early detection of diseases.
Team
Our team consists of people with different backgrounds and skills, but all share a common goal – to improve healthcare, screening and diagnostics with innovative and scientifically-backed solutions.
Jukka Holappa
Chief Business Officer & co-OWNER
Operations and business lead
jukka.holappa@aqbiotech.com
Janne Kulpakko
CHIEF SCIENCE OFFICER & CO-FOUNDER
Leading the company’s research work and new application development.
janne.kulpakko@aqbiotech.com
Elizabeth Cudjoe
SENIOR APPLICATION SCIENTIST
Phage-biosensor research and test development.
elizabeth.cudjoe@aqbiotech.com
Elinda Helin
SENIOR APPLICATION SCIENTIST
Phage-biosensor research and test development
elinda.helin@aqbiotech.com
Raakel Lehmusmäki
APPLICATION SCIENTIST
Phage-biosensor research and test development
raakel.lehmusmaki@aqbiotech.com
Zhao Zhao
PROJECT DIRECTOR
Management of the company’s research and preclinical trials in China.
zhao.zhao@aqbiotech.com
Senior Clinical Advisors
Antti Rannikko
Professor of Urology at Helsinki University Hospital.
Maria Sundvall
MD Phd, Specialist Physician in Clinical Oncology at Turku University Hospital.
Valtteri Kaasinen
MD, PhD and Professor of Neurology in Clinical Neurosciences at Turku University Hospital
Linda Eva Amoah
Associate Professor of Immunology at the Noguchi Memorial Institute for Medical Research.
Tambet Teesalu
Professor of Nanomedicine and the head of the Laboratory of Precision and Nanomedicine at the University of Tartu.
